Patent: 5,215,895
✉ Email this page to a colleague
Summary for Patent: 5,215,895
Title: | DNA encoding a mammalian cytokine, interleukin-11 |
Abstract: | A novel mammalian cytokine, IL-11, and processes for producing it are disclosed. IL-11 may be used in pharmaceutical preparations for stimulating and/or enhancing cells involved in the immune response and cells involved in the proper functioning of the hematopoietic system. |
Inventor(s): | Bennett; Frances K. (Melrose, MA), Paul; Stephen R. (Boston, MA), Yang; Yu-Chung (Indianapolis, IN) |
Assignee: | Genetics Institute, Inc. (Cambridge, MA) |
Application Number: | 07/526,474 |
Patent Claims: | see list of patent claims |
Details for Patent 5,215,895
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Wyeth Pharmaceuticals Inc. | NEUMEGA | oprelvekin | For Injection | 103694 | November 25, 1997 | 5,215,895 | 2010-06-01 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,215,895
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 9107495 | ⤷ Subscribe |
United States of America | 6066317 | ⤷ Subscribe |
United States of America | 5854028 | ⤷ Subscribe |
United States of America | 5700664 | ⤷ Subscribe |
United States of America | 5371193 | ⤷ Subscribe |
Mexico | 9203439 | ⤷ Subscribe |
South Korea | 970005050 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |